SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
35.59
+0.81 (2.33%)
Dec 20, 2024, 4:00 PM EST - Market closed

SpringWorks Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-275.16-325.1-277.42-173.91-45.57-58.31
Upgrade
Depreciation & Amortization
2.991.670.770.490.350.19
Upgrade
Loss (Gain) on Equity Investments
6.455.042.890.990.612.61
Upgrade
Stock-Based Compensation
107.7494.5372.9738.4410.033.11
Upgrade
Other Operating Activities
21.651.130.991.05-
Upgrade
Change in Accounts Receivable
-32.97-5.93----
Upgrade
Change in Inventory
-9.83-3.1----
Upgrade
Change in Accounts Payable
4.01-0.24.172.07-1.31.88
Upgrade
Change in Unearned Revenue
-19.55-19.55---
Upgrade
Change in Other Net Operating Assets
5.528.6514.393.042.653.07
Upgrade
Operating Cash Flow
-208.8-222.8-161.56-127.88-32.19-47.44
Upgrade
Capital Expenditures
-1.1-7.39-10.2-2.02-0.64-0.67
Upgrade
Investment in Securities
-96.4642.14-205.485.61-418.19-3.59
Upgrade
Investing Cash Flow
-108.8134.75-215.683.59-418.83-4.26
Upgrade
Issuance of Common Stock
311.35299.44342.041.16270.49169.75
Upgrade
Repurchase of Common Stock
-8.17-2.8-1.34---
Upgrade
Financing Cash Flow
303.18296.64340.71.16270.49333.71
Upgrade
Net Cash Flow
-14.43108.6-36.46-43.13-180.54282
Upgrade
Free Cash Flow
-209.9-230.18-171.76-129.89-32.83-48.11
Upgrade
Free Cash Flow Margin
-154.92%-4225.81%---93.81%-
Upgrade
Free Cash Flow Per Share
-2.92-3.65-3.22-2.68-0.76-3.62
Upgrade
Levered Free Cash Flow
-114.42-113.19-88.27-63.42-16.15-28.43
Upgrade
Unlevered Free Cash Flow
-114.42-113.19-88.27-63.42-16.15-28.43
Upgrade
Change in Net Working Capital
28.26-12.38-23.62-8.08-3.06-5.97
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.